On November 2, 2024, Simcere Pharmaceutical announced that Sanbexin® sublingual tablets (generic name: edaravone and ...

Globally, it is estimated that more than ten million children, aged five to 11, have uncontrolled respiratory allergies and the number is growing. House dust mites are a common cause of allergy and ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Zolpidem tartrate 1.75mg, 3.5mg. Zolpidem interacts with gamma-aminobutyric acid-benzodiazepine (GABA-BZ) receptor complex and shares some of the pharmacological properties of benzodiazepines.

Danish allergy immunotherapy specialist ALK Abello announced that its European regulatory filing for Acarizax (house dust ...

NANJING, China, Dec. 4, 2024 /PRNewswire/ -- On November 2, 2024, Simcere Pharmaceutical announced that Sanbexin® sublingual tablets (generic name: edaravone and dexborneol sublingual tablets ...

China’s National Medical Products Administration (NMPA) granted new approvals to several Chinese biopharmaceuticals this week, including expanding indications of four different cancer drugs and ...

PNN Ahmedabad Gujarat [India]7 Troikaa Pharma announced that it has launched its Zolpidem Sublingual Spray 385 wv for the ...

Simcere Pharmaceutical Group Limited (HK:2096) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with ...

BioNxt Solutions announces development of sublingual thin-film ODF for Semaglutide: Vancouver, BC Tuesday, December 3, 2024, 17:00 Hrs [IST] BioNxt Solutions Inc., a bioscience co ...

The reputable scientific journal, The Lancet Regional Health – Europe, has published robust results from ALK’s house dust mite sublingual allergy immunotherapy tablet (SLIT-tablet) phase 3 children ...